Rosuvastatin
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Rosuvastatin is a high-intensity statin and one of the most potent agents for lowering LDL cholesterol. The JUPITER trial demonstrated its benefit in primary prevention among patients with elevated high-sensitivity C-reactive protein even without hyperlipidemia.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Rosuvastatin is a high-intensity statin and one of the most potent agents for lowering LDL cholesterol. NutriStack rates the supporting evidence as strong. Common adult dosing is 5–40 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 12 sources.
- Myalgia and muscle pain
- Headache
- Nausea and abdominal pain
- Active liver disease or unexplained persistent transaminase elevations7
- Pregnancy and breastfeeding
The bottom line
Evidence rating strong. Most-documented uses: lowers ldl cholesterol by 45–63%, reduces cardiovascular events in primary and secondary prevention, raises hdl cholesterol modestly. 12 sources indexed (2021–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively and competitively inhibits HMG-CoA reductase in the liver. Rosuvastatin is hydrophilic with high hepatic selectivity, resulting in potent LDL-C reduction with relatively lower systemic muscle exposure. Upregulates hepatic LDL receptors, increases LDL clearance, and reduces VLDL synthesis.2,3
Dosing & protocol.
Can be taken with or without food at any time of day; hydrophilic statin not dependent on CYP3A4 metabolism3
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
ModerateHMG-CoA reductase inhibition reduces mevalonate pathway flux, lowering endogenous CoQ10 synthesis alongside cholesterol synthesis.
Full safety detail.
Side effects
- Myalgia and muscle pain
- Headache
- Nausea and abdominal pain
- Elevated liver transaminases
- Proteinuria (at higher doses)
- Rhabdomyolysis (rare but serious)
- New-onset diabetes (modest increased risk)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Statin use and dementia risk: A systematic review and updated meta-analysisPMIDWestphal Filho FL, Moss Lopes PR, Menegaz de Almeida A, Sano VKT et al. · Alzheimer's & Dementia (New York, N. Y.) · 2025
Statin use, particularly with lipophilic statins, was associated with a significant reduction in dementia risk in this updated systematic review and meta-analysis
- 2The pharmacogenetics of rosuvastatin and implications for treatment: a systematic reviewPMIDGonzález-Iglesias E, Novalbos J, Abad-Santos F · Pharmacogenomics · 2025
González-Iglesias E, Novalbos J, Abad-Santos F. The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review. Pharmacogenomics. 2025
- 3Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic ReviewPMIDKang Y, Park JM, Lee SH · Yonsei Medical Journal · 2024
Moderate-intensity rosuvastatin/ezetimibe combination therapy showed comparable or superior LDL-C reduction to quadruple-dose rosuvastatin monotherapy with potentially fewer side effects
- 4Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysisPMIDLiu L, Deng Y, Li L et al. · PloS one · 2024
Liu L, Deng Y, Li L et al.. Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. PloS one. 2024
- 5Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysisPMIDSingh H, Kaur S, Kaushal P et al. · Expert review of clinical pharmacology · 2024
Singh H, Kaur S, Kaushal P et al.. Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis. Expert review of clinical pharmacology. 2024
- 6Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy AdultsPMIDKanukula R, Salam A, Rodgers A et al. · Clinical pharmacokinetics · 2021
Kanukula R, Salam A, Rodgers A et al.. Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults. Clinical pharmacokinetics. 2021
Randomized controlled trials
1- 7The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 StudyPMIDMoon JS, Park IR, Kim SS et al. · Diabetes & metabolism journal · 2023
Moon JS, Park IR, Kim SS et al.. The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study. Diabetes & metabolism journal. 2023
Reference material
5- 8Ridker PM et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). N Engl J Med. 2008.Source linkedPMID
- 9Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. Lancet. 2002.Source linkedPMID
- 10Nissen SE et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis (ASTEROID). JAMA. 2006.Source linkedPMID
- 11Zhang L, Zhang S, Yu Y et al.. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations. Herz. 2020Source linkedPMID
- 12Lamb YN. Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2020Source linkedPMID
Common questions.
Quick answers about Rosuvastatin, drawn from the data on this page.
What is Rosuvastatin?
Rosuvastatin is a high-intensity statin and one of the most potent agents for lowering LDL cholesterol. The JUPITER trial demonstrated its benefit in primary prevention among patients with elevated high-sensitivity C-reactive protein even without hyperlipidemia.
What is Rosuvastatin used for?
Commonly cited benefits of Rosuvastatin include: Lowers LDL cholesterol by 45–63%; Reduces cardiovascular events in primary and secondary prevention; Raises HDL cholesterol modestly; Reduces triglycerides. NutriStack rates the overall evidence as strong.
What is a typical dose of Rosuvastatin?
A typical adult dose of Rosuvastatin is 5–40 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Rosuvastatin?
Reported side effects include myalgia and muscle pain, headache, nausea and abdominal pain, elevated liver transaminases, proteinuria (at higher doses), rhabdomyolysis (rare but serious). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Rosuvastatin?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Rosuvastatin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.